Equity
€338,621 from €935,427 in 2017
Equity fell by 64% in 8 years.
EXPLEO LIFE SCIENCES BELGIUM
Lifetime
18 annual accounts with figures on one time axispeak €10.9m (2018)
-not published
lowest -€1.3m (2018)
-€46,074▲ €347,595
peak €935,427 (2017)
€338,621▲ 57.1%
€550,535▼ 46.7%
peak 105.1 FTE (2018)
9.6 FTE▼ 52.5%
Board7 names since 2019
1 directorDamien LASOU
Owners5 names in the annual accounts
100%EXPLEO SAS
Documentsfilings and deeds
22-05-202670 days before the deadline
2025financial year
Gross margin from €1.7m to €908,980Loss of €46,074Staff from 20.2 FTE to 9.6 FTECapital increase · Amendment of the articles 03-12Resignation: Alexis D'Elia (daily management delegate) 29-10Equity from €215,515 to €338,621
Key points
from the 2025 annual accounts, the last ones filedLosses
-€2.7m in eight years
Every financial year from 2018 to 2025 closed with a loss. 2018 was the heaviest.
Staff
9.6 FTE from 105.1 in 2018
Between 2018 and 2025, 91% of the full-time equivalents disappeared. Last accounts before the absorption by Group Expleo Technology Belgium (effective 01-08-2026).
No scoreEquity +57%: capital increase
Recent changes
Reappointment: SRL DELOITTE Réviseurs d'Entreprises (statutory auditor)
General meeting of 15-05-2026 · Gazette deed
Merger: absorbed by SRL GROUP EXPLEO TECHNOLOGY BELGIUM
Dissolution of the company · Dissolved without liquidation on 01-08-2026 · Books and records kept by the absorbing company · General meeting of 31-07-2026 · Gazette deed
Merger proposal: to be absorbed by Group Expleo Technology Belgium
Gazette deed
Listed in the Peppol Directory
Official details
Source: KBO- Status
- Absorbed by Group Expleo Technology Belgiummerger by absorption, August 2026
- Legal form
- Public limited company
- Activity
- “La société a pour objet toutes activités de centralisation de trésorerie pour l'ensemble des…” (deed in French)From the articles, 4 activitiesNo NACE code in the KBO yet
- Joint committee
- 200Auxiliary committee for white-collar workers · annual accounts 2023
- Financial year end
- 31 December
- Peppol
- Reachable since 12-12-2025
Annual accounts 2025
- ≈ €2.1mestimated
- €939,156▼ 27.7%
- Employeeson 31-12-2025
- 6▼ 60.0%
- Filing
- Filed on 22-05-2026
Insights on EXPLEO LIFE SCIENCES BELGIUM
EXPLEO LIFE SCIENCES BELGIUM reached its highest turnover since 2009 in 2018: €10.9m. A year later it was €9.6m, and in 2020 still €7.2m.
Equity fell from €935,427 in 2017 to €338,621 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about EXPLEO LIFE SCIENCES BELGIUM
- What is the company number of EXPLEO LIFE SCIENCES BELGIUM?
- The company number of EXPLEO LIFE SCIENCES BELGIUM is 0890.368.245. The VAT number is the same number with BE in front: BE 0890.368.245.
- What is the legal form of EXPLEO LIFE SCIENCES BELGIUM?
- EXPLEO LIFE SCIENCES BELGIUM is a public limited company (NV).
- Is EXPLEO LIFE SCIENCES BELGIUM still active?
- No. EXPLEO LIFE SCIENCES BELGIUM is inactive in the KBO register.Company details
- How many employees did EXPLEO LIFE SCIENCES BELGIUM have?
- EXPLEO LIFE SCIENCES BELGIUM had an average of 9.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does EXPLEO LIFE SCIENCES BELGIUM fall under?
- In its 2023 annual accounts, EXPLEO LIFE SCIENCES BELGIUM states joint committee 200 (Auxiliary committee for white-collar workers).
- What is the turnover of EXPLEO LIFE SCIENCES BELGIUM?
- The turnover in financial year 2025 is ≈ €2.1m. This figure is estimated from the gross margin of €908,980 and 2,275 comparable companies of the same size. It probably lies between €1.3m and €3.6m. It is a rough estimate. In financial year 2021 turnover was €5.1m.
- Is EXPLEO LIFE SCIENCES BELGIUM profitable?
- In financial year 2025, EXPLEO LIFE SCIENCES BELGIUM made a loss of €46,074.
- Where can I find the annual accounts of EXPLEO LIFE SCIENCES BELGIUM?
- EXPLEO LIFE SCIENCES BELGIUM filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.